Hear from Nobel laureate Jennifer Doudna on the four ways that CRISPR gene editing technologies will revolutionize healthcare.
In her 31 March talk at the Frontiers Forum, Prof Jennifer Doudna outlined how CRISPR-based therapies are already transforming the lives of patients with previously limited treatment options. She also gave her vision for how her serendipitous discovery will revolutionize healthcare for us all. The session was attended by over 9,200 representatives from science, policy and business across the world.
Jennifer's keynote talk was followed by a discussion with global experts on access and ethical considerations:
• Prof Andrea Crisanti, Imperial College London
• Prof Françoise Baylis, Dalhousie University
• Dr Soumya Swaminathan, Chief Scientist, World Health Organization
2022 marks the 10th anniversary of Jennifer’s groundbreaking development of CRISPR-Cas9 as a genome-engineering technology, with collaborator Prof Emmanuelle Charpentier. The two earned the 2020 Nobel Prize in Chemistry for their work, which has forever changed the course of human and agricultural genomics research. Jennifer Doudna is the Li Ka Shing Chancellor’s Chair and a Professor in the Departments of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley, and Founder of the Innovative Genomics Institute.
The Frontiers Forum showcases science-led solutions for healthy lives on a healthy planet. Watch previous sessions at [ Ссылка ]
MAIN TALK
00:00:00 Opening
00:00:39 Welcome & introduction | Kamila Markram, Frontiers CEO & Co-founder
00:03:20 Keynote excerpt | Jennifer Doudna
00:03:31 Treatments for (almost) all disease | Jennifer Doudna
00:06:08 Off-the-shelf therapeutics | Jennifer Doudna
00:07:07 Faster diagnostics & drug discovery | Jennifer Doudna
00:09:12 Preventative health | Jennifer Doudna
EXPERT CONTRIBUTORS
00:11:46 CRISPR gene drives | Andrea Crisanti, Imperial College London
00:18:40 Response from Jennifer Doudna
00:21:12 Societal consensus for genome editing | Françoise Baylis, Dalhousie University
00:26:53 Response from Jennifer Doudna
00:30:12 Access to gene-editing therapies | Soumya Swaminathan, WHO
00:37:56 Response from Jennifer Doudna
00:41:27 Response from Soumya Swaminathan
00:42:59 Response from Françoise Baylis
00:44:28 Response from Andrea Crisanti
00:45:54 Response from Jennifer Doudna
AUDIENCE Q&A
00:46:59 Cell specificity of gene editing | Laure Marignol
00:47:46 Response from Jennifer Doudna
00:49:35 Editing of genes for human behavior | Sangwon Suh
00:51:20 Response from Jennifer Doudna
00:52:05 Response from Françoise Baylis
00:55:01 CRISPR to tackle antimicrobial resistance | Mukteswar Mothadaka
00:55:13 Response from Jennifer Doudna
00:56:23 Gene editing for space adaptation | Sotirios Zarogiannis
00:56:58 Response from Jennifer Doudna
00:57:25 Closing
